News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
256,095 Results
Type
Article (13716)
Company Profile (257)
Press Release (242122)
Section
Business (79144)
Career Advice (147)
Deals (13166)
Drug Delivery (28)
Drug Development (50136)
Employer Resources (31)
FDA (5631)
Job Trends (5104)
News (143553)
Policy (10011)
Tag
Academia (903)
Africa (145)
Allergies (30)
Alliances (21397)
Alzheimer's disease (680)
Antibody-drug conjugate (ADC) (31)
Approvals (5594)
Arizona (38)
Artificial intelligence (28)
Asia (16624)
Australia (2775)
Bankruptcy (96)
Best Places to Work (4337)
Biotechnology (215)
C2C Services and Suppliers (10606)
California (1160)
Canada (478)
Cancer (243)
Career advice (128)
CAR-T (33)
Cell therapy (91)
China (83)
Clinical research (38960)
Collaboration (80)
Colorado (34)
Compensation (34)
Connecticut (38)
COVID-19 (980)
Cystic fibrosis (58)
Data (165)
Diabetes (36)
Diagnostics (1154)
Earnings (28352)
Employer resources (29)
Europe (35632)
Events (45715)
Executive appointments (87)
FDA (5729)
Florida (115)
Funding (91)
Gene therapy (76)
Georgia (27)
GLP-1 (259)
Government (1051)
Healthcare (6509)
Hotbed/Location (184149)
Illinois (70)
Indiana (42)
Infectious disease (989)
Inflammatory bowel disease (77)
IPO (7127)
Job creations (856)
Job search strategy (124)
Kansas (52)
Layoffs (177)
Legal (1368)
Lung cancer (55)
Maryland (174)
Massachusetts (944)
Medical device (2513)
Medtech (2514)
Mergers & acquisitions (6031)
Metabolic disorders (125)
Michigan (37)
Minnesota (65)
Neuroscience (776)
New Jersey (310)
New York (376)
NextGen Class of 2024 (1976)
Non-profit (838)
North Carolina (320)
Northern California (511)
Obesity (72)
Ohio (61)
Opinion (86)
Parkinson's disease (29)
Patents (34)
Peanut (27)
Pennsylvania (269)
People (24679)
Pharmaceutical (41)
Phase I (13670)
Phase II (18115)
Phase III (11529)
Pipeline (67)
Postmarket research (842)
Preclinical (5760)
Press Release (30)
Rare diseases (100)
Real estate (1406)
Regulatory (8002)
Research institute (930)
South America (206)
Southern California (482)
Startups (1963)
Texas (104)
United States (4477)
Vaccines (126)
Washington State (165)
Weight loss (56)
Date
Today (14)
Last 7 days (385)
Last 30 days (1167)
Last 365 days (21410)
2024 (14793)
2023 (22418)
2022 (26825)
2021 (27810)
2020 (23359)
2019 (16224)
2018 (11738)
2017 (13747)
2016 (11843)
2015 (14352)
2014 (10393)
2013 (7485)
2012 (7532)
2011 (7616)
2010 (7430)
256,095 Results for "immunomic therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Immunome Appoints Phil Tsai as Chief Technical Officer
Immunome, Inc. today announced the appointment of Phil Tsai, PhD, as Chief Technical Officer.
June 27, 2024
·
5 min read
Business
Immunome Announces Completion of Purchase of Assets from Atreca
Immunome, Inc. today announced the completion of its purchase of antibodies and related assets from Atreca, Inc.
May 20, 2024
·
4 min read
Business
Immunome Announces Promotion of Max Rosett to Chief Financial Officer
Immunome, Inc. today announced the promotion of Max Rosett to Chief Financial Officer, effective May 9.
May 17, 2024
·
5 min read
Business
Immunome Reports First Quarter 2024 Financial Results and Provides Business Update
Immunome, Inc. today announced financial results for the first quarter ended March 31, 2024, and provided a business update.
May 14, 2024
·
8 min read
Business
Immunome Appoints Kinney Horn as Chief Business Officer
Immunome, Inc., a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced the appointment of Kinney Horn as Chief Business Officer.
May 2, 2024
·
5 min read
BioForest
Immunome to Present at 2024 Bank of America Healthcare Conference
Immunome, Inc. today announced that Clay Siegall, PhD, President and Chief Executive Officer, will present at the 2024 Bank of America Healthcare Conference on Wednesday, May 15, 2024 at 10:40 A.M. Pacific Time.
May 8, 2024
·
1 min read
Business
Immunome Appoints Sandra M. Swain to Board of Directors
Immunome, Inc., a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced the appointment of Sandra M. Swain, M.D., to its Board of Directors.
April 25, 2024
·
5 min read
BioForest
Immunome to Participate in the Leerink Partners Global Biopharma Conference
Immunome, Inc. today announced that Clay Siegall, Ph.D., President and CEO of Immunome, will present at the Leerink Partners 2024 Global Biopharma Conference on Tuesday, March 12, 2024 at 4:20 p.m. ET.
March 7, 2024
·
1 min read
Pharm Country
Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome
Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completion of the previously announced sale of AL102, and related drug candidate AL101, to Immunome, Inc. (Nasdaq: IMNM).
March 26, 2024
·
2 min read
BioForest
Immunome to Participate in the TD Cowen 44th Annual Healthcare Conference
Immunome, Inc. today announced that Clay Siegall, PhD, President and CEO of Immunome, will participate in a targeted oncology panel at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024 at 12:50 p.m. ET.
March 1, 2024
·
1 min read
1 of 25,610
Next
